Bank Of America Corp Decibel Therapeutics, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$2.08 - $4.79 $83 - $191	-40 Reduced 5.06%	750 $2,000
Q4 2022 Feb 10, 2023	SELL	$1.86 - $3.54 $8,321 - $15,837	-4,474 Reduced 84.99%	790 $1,000
Q3 2022 Nov 14, 2022	SELL	$3.82 - $5.61 $21,709 - $31,881	-5,683 Reduced 51.91%	5,264 $19,000
Q2 2022 Aug 12, 2022	SELL	$1.85 - $4.21 $14,322 - $32,593	-7,742 Reduced 41.43%	10,947 $46,000
Q1 2022 May 16, 2022	BUY	$2.83 - $5.03 $14,053 - $24,978	4,966 Added 36.19%	18,689 $56,000

Q4 2021 Feb 08, 2022	SELL	$4.57 - $8.58 $25,363 - $47,619	-5,550 Reduced 28.8%	13,723 $64,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $9.04 $119,334 - $163,452	18,081 Added 1516.86%	19,273 $148,000
Q2 2021 Sep 13, 2021	BUY	$6.39 - $11.51 $7,616 - $13,719	1,192 New	1,192 $10,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.